M. Salomonsson et al., EFFECTS OF STIMULATION AND INHIBITION OF PROTEIN-KINASE-C ON THE CYTOSOLIC CALCIUM-CONCENTRATION IN RABBIT AFFERENT ARTERIOLES, Acta Physiologica Scandinavica, 161(3), 1997, pp. 271-279
The effect oi the protein kinase C (PKC) inhibitor chelerytrine (Ch) a
nd the PKC activator 12-0-tetradecanoyl-phorbol-13-acetate (TPA) on th
e cytosolic calcium concentration ([Ca2+](i)) in isolated intact rabbi
t afferent arterioles was investigated. [Ca2+](i) was measured in the
proximal and distal parts oi the arteriole. Administration of 1 mu M C
h gave rise to a peak followed by an elevated level of [Ca2+](i) in bo
th these parts. Neither the peal: nor the elevated level of [Ca2+](i)
was significantly reduced by 1 mu M nifedipine. The relative peak incr
ease in [Ca2+](i) in response to 1 mu M noradrenaline (NA) or to 10 nM
angiotensin ii (All) was significantly blunted in both parts after pr
eincubation with 1 mu M Ch. Depolarization with 25 mM K+ increased [Ca
2+](i) in both parts. Preincubation with Ch did not affect the increas
e in [Ca2+](i) induced by 25 mM K+. TPA (10 and 100 nM) did not signif
icantly affect the basal [Ca2+](i) in the afferent arteriole. The [Ca2
+](i) response to NA or 25 mM K+ was not affected by TPA. We conclude
that blockade of PKC, increases [Ca2+](i) in afferent arteriolar smoot
h muscle by a mechanism independent of L-type voltage-sensitive calciu
m channels. Inhibition of PKC blunts the relative increase in [Ca2+](i
) in response to All and, to a lesser extent, that induced by NA. We c
onclude that PKC might be important in modulating the calcium changes
that occur in response to these vasoconstrictors.